<乌鸦传媒>Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCL Patients with treatment-sensitive disease may benefit most from continued treatment, says expert Dec 05, 2023
<乌鸦传媒>After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasms Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge Dec 04, 2023
<乌鸦传媒>Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS 40% of patients treated with imetelstat were transfusion-free for at least 8 weeks Dec 04, 2023
<乌鸦传媒>'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene? Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance Dec 04, 2023
<乌鸦传媒>First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years Dec 04, 2023
<乌鸦传媒>Non-Covalent BTK Inhibitor Approved for CLL Response rates with pirtobrutinib reached 72% in heavily pretreated patient population Dec 04, 2023
<乌鸦传媒>Charting the Course: From Young Adult Leukemia Patient to Oncologist My experience shaped how I care for patients today Dec 03, 2023
<乌鸦传媒>Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish News, features, and commentary about cancer-related issues Dec 01, 2023
<乌鸦传媒>Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape" Dec 01, 2023
<乌鸦传媒>Breast Cancer Screening Frequency Makes a Big Survival Difference Keeping those mammogram appointments is life-saving, study finds Nov 30, 2023
<乌鸦传媒>Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer Investigational intravesical solution led to complete response rate of 79% Nov 30, 2023
<乌鸦传媒>Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer And our roundtable of experts discuss selinexor for wild-type p53 disease Nov 30, 2023 video
<乌鸦传媒>AI Model Can Predict Breast Cancer Risk Regardless of Patient's Race Algorithm proved accurate where traditional risk models have failed, but needs more testing Nov 30, 2023
<乌鸦传媒>With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokers Tool could identify nonsmokers most likely to benefit from low-dose CT screening Nov 29, 2023
<乌鸦传媒>FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy Applies to all approved therapies, but benefits still outweigh risks, agency says Nov 28, 2023
<乌鸦传媒>Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screening The strategy was effective for patients who were due or overdue for screening Nov 28, 2023
<乌鸦传媒>FDA Approves First Therapy for Progressive Desmoid Tumors Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial Nov 28, 2023
<乌鸦传媒>Diagnostic Imaging Not Yet Enough for Biopsy-Free Radical Prostatectomy Study validates concerns about benign prostatic hyperplasia-related PSMA-PET false positives Nov 27, 2023
<乌鸦传媒>Chemoimmunotherapy Improves Pathologic Outcomes in Gastroesophageal Carcinoma Adding atezolizumab to FLOT led to more downstaging, complete regressions versus chemo alone Nov 24, 2023
<乌鸦传媒>Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations Researchers suggest the drug is a promising option for this rare subgroup Nov 22, 2023
<乌鸦传媒>Cancer Patient's Final Act: Destroying Medical Debt Viral campaign will erase some $60 million in medical debt Nov 22, 2023
<乌鸦传媒>Cancer Drug Recall; Long COVID and Reinfection; WHO Staffer Killed in Gaza Health news and commentary from around the Web gathered by 乌鸦传媒 staff Nov 22, 2023
<乌鸦传媒>HPV Tumor DNA May Offer Early Warning of Cervical Cancer at High Risk of Relapse Worse PFS associated with circulating tumor DNA detected as early as end of treatment Nov 21, 2023
<乌鸦传媒>Apixaban Prophylaxis Fails to Reduce Clots in Pediatric ALL However, it may benefit children at increased risk of thrombosis Nov 20, 2023
<乌鸦传媒>Alteplase Not Harmful in NOAC Users, Even in a More Bleeding-Prone Cohort No excess brain bleeds in an Asian population receiving lytic therapy for stroke Nov 20, 2023
<乌鸦传媒>Nudging Parents Plus Auditing Providers Increased HPV Vaccine Uptake in Tweens Interventions worked best in combination, according to cluster randomized trial Nov 20, 2023
<乌鸦传媒>Shooting at Psych Hospital; Rosalynn Carter Dies; Millions in Medical Debt Canceled Health news and commentary from around the Web gathered by 乌鸦传媒 staff Nov 20, 2023
<乌鸦传媒>Reprogramming Tumors; Bad Stool Samples; Human Experiences in Cancer Care News, features, and commentary about cancer-related issues Nov 17, 2023
<乌鸦传媒>First AKT Inhibitor Approved for Advanced Breast Cancer Capivasertib plus fulvestrant doubled progression-free survival versus fulvestrant-placebo Nov 17, 2023
<乌鸦传媒>Opioid Doc Sentenced; World's First Sickle Cell Gene Tx; FTC Warns Diet Influencers Health news and commentary from around the Web gathered by 乌鸦传媒 staff Nov 17, 2023
<乌鸦传媒>FDA Panel: Tolerating Approval Outliers Would Set 'Dangerous Precedent' No easy answers for two drugs for rare lymphoma on long cruise with accelerated approval Nov 16, 2023
<乌鸦传媒>ASTRO Updates Guidelines on Partial Breast Irradiation for Early Invasive Cancer Evidence from RCTs indicates "oncologic equivalence" between partial and whole-breast irradiation Nov 16, 2023
<乌鸦传媒>FDA OKs New Option for Advanced ROS1-Positive Lung Cancer Drug achieved high response rates in TKI-naive and TKI-pretreated patients Nov 16, 2023
<乌鸦传媒>'We're Not There Yet': CAR T-Cell Therapy for Renal Cell Carcinoma Potential standard of care after current therapies, but key obstacles remain in the way Nov 15, 2023
<乌鸦传媒>FDA OKs Product to Thwart Bloodstream Infections During Dialysis Taurolidine-heparin solution reduced infections by 71% versus heparin alone Nov 15, 2023
<乌鸦传媒>Targeting New Pathways to Improve Outcomes in Renal Cell Carcinoma Building on recent success requires intervention at multiple steps in the cancer immunity cycle Nov 14, 2023
<乌鸦传媒>Lymphoma Drug Copanlisib to Be Pulled From U.S. Market Failed confirmatory trial takes down another PI3K inhibitor Nov 14, 2023
<乌鸦传媒>Diabetes Linked to Higher Colorectal Cancer Risk Associated risks highest in those with recent diagnoses Nov 14, 2023
<乌鸦传媒>No Boost in Outcomes for Clear Cell RCC With Higher Belzutifan Dose A quarter of patients responded whether at the recommended or higher dose Nov 13, 2023
